RESEARCHERS ANNOUNCE LIVER CANCER TREATMENT
At today’s annual meeting of the American Society of Clinical Oncology (ASCO), researchers announced the results of a clinical trial of Nexavar. The drug, made by Bayer, was used in a clinical trial which was stopped early due to the overwhelmingly good response. The liver cancer patients who took Nexavar had 44% more time to…
read more